BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 15505758)

  • 1. Prediction of relapse after antithyroid drug therapy of Graves' disease: value of color Doppler sonography.
    Saleh A; Cohnen M; Fürst G; Mödder U; Feldkamp J
    Exp Clin Endocrinol Diabetes; 2004 Oct; 112(9):510-3. PubMed ID: 15505758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid vascularization by color doppler ultrasonography in Graves' disease. Changes related to different phases and to the long-term outcome of the disease.
    Baldini M; Castagnone D; Rivolta R; Meroni L; Pappalettera M; Cantalamessa L
    Thyroid; 1997 Dec; 7(6):823-8. PubMed ID: 9459623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of antithyroid drug dose in Graves' disease: value of quantification of thyroid blood flow with color duplex sonography.
    Saleh A; Fürst G; Feldkamp J; Godehardt E; Grust A; Mödder U
    Ultrasound Med Biol; 2001 Aug; 27(8):1137-41. PubMed ID: 11527601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Color Doppler sonography in Graves' disease: value in assessing activity of disease and predicting outcome.
    Castagnone D; Rivolta R; Rescalli S; Baldini MI; Tozzi R; Cantalamessa L
    AJR Am J Roentgenol; 1996 Jan; 166(1):203-7. PubMed ID: 8571877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of colour Doppler sonography in patients with Graves' disease.
    Kumar KV; Vamsikrishna P; Verma A; Muthukrishnan J; Rayudu BR; Modi KD
    West Indian Med J; 2009 Dec; 58(6):566-70. PubMed ID: 20583684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential diagnosis of hyperthyroidism: Doppler sonographic quantification of thyroid blood flow distinguishes between Graves' disease and diffuse toxic goiter.
    Saleh A; Cohnen M; Fürst G; Godehardt E; Mödder U; Feldkamp J
    Exp Clin Endocrinol Diabetes; 2002 Jan; 110(1):32-6. PubMed ID: 11835123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of anti-thyroid drug treatment duration on thyroid gland microvessel density and intraoperative blood loss in patients with Graves' disease.
    Erbil Y; Giriş M; Salmaslioglu A; Ozluk Y; Barbaros U; Yanik BT; Kapran Y; Abbasoglu SD; Ozarmagan S
    Surgery; 2008 Feb; 143(2):216-25. PubMed ID: 18242338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease.
    Quadbeck B; Hoermann R; Roggenbuck U; Hahn S; Mann K; Janssen OE;
    Thyroid; 2005 Sep; 15(9):1047-54. PubMed ID: 16187913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid blood flow evaluation by color-flow Doppler sonography distinguishes Graves' disease from Hashimoto's thyroiditis.
    Vitti P; Rago T; Mazzeo S; Brogioni S; Lampis M; De Liperi A; Bartolozzi C; Pinchera A; Martino E
    J Endocrinol Invest; 1995 Dec; 18(11):857-61. PubMed ID: 8778158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid blood flow as a useful predictor of relapse of Graves' disease after normal delivery in patients with Graves' disease.
    Nagasaki T; Inaba M; Fujiwara-Ueda M; Nishio J; Kumeda Y; Hiura Y; Tahara H; Ishimura E; Ishiko O; Nishizawa Y
    Biomed Pharmacother; 2010 Feb; 64(2):113-7. PubMed ID: 20006462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of thyroid blood flow as a predictor of methimazole sensitivity in untreated hyperthyroid patients with Graves' disease.
    Nagasaki T; Inaba M; Kumeda Y; Fujiwara-Ueda M; Hiura Y; Nishizawa Y
    Biomed Pharmacother; 2007 Sep; 61(8):472-6. PubMed ID: 17420111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of flowmetric analysis and of color-Doppler ultrasonography with contrast media in the different phases and follow-up of Graves' disease].
    Amodio F; Di Martino S; Esposito S; Iorio S; Hierholzer J; Rea G; Bizzarro A; Vallone G
    Radiol Med; 2001 Oct; 102(4):233-7. PubMed ID: 11740450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the measurement of inferior thyroid artery blood flow velocity by color-flow Doppler ultrasonography useful for differential diagnosis between gestational transient thyrotoxicosis and Graves' disease? A prospective study.
    Zuhur SS; Ozel A; Velet S; Buğdacı MS; Cil E; Altuntas Y
    Clinics (Sao Paulo); 2012; 67(2):125-9. PubMed ID: 22358236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relapse of Graves' disease after successful outcome of antithyroid drug therapy: results of a prospective randomized study on the use of levothyroxine.
    Hoermann R; Quadbeck B; Roggenbuck U; Szabolcs I; Pfeilschifter J; Meng W; Reschke K; Hackenberg K; Dettmann J; Prehn B; Hirche H; Mann K;
    Thyroid; 2002 Dec; 12(12):1119-28. PubMed ID: 12593726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doppler ultrasonography in predicting relapse of hyperthyroidism in Graves' disease.
    Varsamidis K; Varsamidou E; Mavropoulos G
    Acta Radiol; 2000 Jan; 41(1):45-8. PubMed ID: 10665869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term follow up after antithyroid drug treatment in Graves' disease].
    Wille T; Müller B; Noth D; Bürgi U; Diem P
    Praxis (Bern 1994); 2006 Jul; 95(29-30):1121-7. PubMed ID: 16916174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
    Roti E; Gardini E; Minelli R; Bianconi L; Salvi M; Gavaruzzi G; Braverman LE
    J Clin Endocrinol Metab; 1993 Apr; 76(4):928-32. PubMed ID: 7682562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Color Doppler measurement of blood flow in the inferior thyroid artery in patients with autoimmune thyroid diseases.
    Caruso G; Attard M; Caronia A; Lagalla R
    Eur J Radiol; 2000 Oct; 36(1):5-10. PubMed ID: 10996751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between the sonographic appearance of the thyroid and the clinical course and autoimmune activity of Graves' disease.
    Baldini M; Orsatti A; Bonfanti MT; Castagnone D; Cantalamessa L
    J Clin Ultrasound; 2005 Oct; 33(8):381-5. PubMed ID: 16240426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of Graves' disease after antithyroid drug treatment in Taiwan.
    Wang PW; Liu RT; Tung SC; Chien WY; Lu YC; Chen CH; Kuo MC; Hsieh JR; Wang ST
    J Formos Med Assoc; 1998 Sep; 97(9):619-25. PubMed ID: 9795530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.